Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E for Prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 233 adverse event reports in the FDA FAERS database where RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E was used for Prophylaxis.

Most Reported Side Effects for RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E

Side Effect Reports % Deaths Hosp.
Herpes zoster 112 24.2% 0 11
Pain 93 20.1% 1 24
Vaccination failure 74 16.0% 0 8
Rash 64 13.8% 0 15
Pyrexia 50 10.8% 2 20
Fatigue 48 10.4% 0 11
Drug ineffective 44 9.5% 0 14
Nausea 40 8.6% 0 10
Pain in extremity 38 8.2% 0 15
Arthralgia 36 7.8% 0 9
Dyspnoea 33 7.1% 2 14
Headache 33 7.1% 0 8
Pruritus 32 6.9% 0 5
Diarrhoea 31 6.7% 1 11
Asthenia 27 5.8% 1 16

Other Indications for RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E

Product used for unknown indication (75) Immunisation (52) Herpes zoster immunisation (22) Herpes zoster (17) Antiviral prophylaxis (5)

Other Drugs Used for Prophylaxis

PEGFILGRASTIM (7,424) HUMAN C1-ESTERASE INHIBITOR (5,950) DENOSUMAB (4,541) SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197) ASPIRIN (2,083) VALACYCLOVIR (1,574) PANTOPRAZOLE (1,502) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444) CLOPIDOGREL BISULFATE (1,296) ENOXAPARIN (1,278)

Related Pages

RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E Full Profile All Prophylaxis Drugs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E Demographics RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E Timeline